Comag Marketing Group, LLC

The suit, brought by a whisle-blowing pharmacist, alleged that CVS improperly switched Medicaid customers to a more-expensive form of a drug in order to receive a higher level of reimbusement from the government program, which provides health care to low income Americans.  CVS said the $36.7 million settlement would not affect its 2008 earnings.  It will, however, provide a $4.3 million windfall to Bernard Lisitza, the pharmacist who first brought the suit.  The Wall Street Journal  (Mar. 19, 2008)  Paid subscription may be required.

Tags: CVS, CVS Caremark, lawsuit settlement

This entry was posted on Wednesday, March 19th, 2008 at 11:24 am and is filed under Drugstore, Retail, Retail - U.S.. You can Email This Article to a friend. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.